FDA Law Blog: Biosimilars

JUNE 3, 2025

We received a response to our post on the prescribing red flags indicating the likelihood of certain prescriptions filled by Walgreens pharmacies were invalid because they lacked a legitimate medical purpose or were not issued in the usual course of professional practice. 50,372, 50,375, (June 13, 2024). By Larry K.

Prescription Filling 59

Prescription Filling Controlled Substances 59

Putting Patients First Blog

JANUARY 27, 2025

Formulary Inclusion and Placement of Generics and Biosimilars The NHC supports CMS proposals to improve formulary practices by prioritizing access to generics, biosimilars, and other cost-effective medications in the Medicare Part D program.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Safe Biologics

MARCH 10, 2025

Small molecule drugs make up over 90% of prescriptions filled in the U.S. A recent survey of doctors who prescribe biosimilars found that only 11% of physicians believe all biosimilars should be deemed interchangeable. Ben Ray Lujn, D-New Mexico, has supported efforts to loosen biosimilar standards.

Biosimilars 130

Biosimilars Independent Pharmacies Drug Pricing Vaccines 130